Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: May 29, 2023

Patent: 10,450,613

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 10,450,613
Title:EGFR/NEDD9/TGF-.beta. interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
Abstract: Compositions and methods for the treatment and diagnosis of cancer are disclosed.
Inventor(s): Astsaturov; Igor (Philadelphia, PA), Golemis; Erica A. (Oreland, PA), Serebriiskii; Ilya G. (Rockledge, PA), Weiner; Louis M. (Washington, DC)
Assignee: Fox Chase Cancer Center (Philadelphia, PA)
Application Number:15/171,663
Patent Claims:see list of patent claims

Details for Patent 10,450,613

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company ERBITUX cetuximab Injection 125084 02/12/2004 ⤷  Try a Trial 2027-11-09
Eli Lilly And Company ERBITUX cetuximab Injection 125084 03/28/2007 ⤷  Try a Trial 2027-11-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.